Abstract
Among the few well characterized virulence factors of Mycobacterium tuberculosis (Mtb) is the heparinbinding hemagglutinin (HBHA). HBHA is a 21-kDa protein that localizes to the mycobacterial surface where it can interact with host components. Interaction with epithelial cells and components of the extracellular matrix is mediated by the methylated lysine-rich C-terminal domain of the protein. The N-terminal end of HBHA contains a coiled coil motif which is involved in protein oligomerization and bacterial-bacterial aggregation. In this report, we will focus our attention on what is known about the structure of the HBHA protein and the protein function and role in TB pathogenesis.
Keywords: Tuberculosis, heparin binding hemagglutinin, adhesion, Mycobacterium tuberculosis, coiled coil motif, bacterial-bacterial aggregation, C-terminal domain, TB pathogenesis, etiologic agent, gram-negative bacteria
Protein & Peptide Letters
Title:Impact of Structural Domains of the Heparin Binding Hemagglutinin of Mycobacterium tuberculosis on Function
Volume: 19 Issue: 10
Author(s): Giovanni Delogu, Giovanni Fadda and Michael J. Brennan
Affiliation:
Keywords: Tuberculosis, heparin binding hemagglutinin, adhesion, Mycobacterium tuberculosis, coiled coil motif, bacterial-bacterial aggregation, C-terminal domain, TB pathogenesis, etiologic agent, gram-negative bacteria
Abstract: Among the few well characterized virulence factors of Mycobacterium tuberculosis (Mtb) is the heparinbinding hemagglutinin (HBHA). HBHA is a 21-kDa protein that localizes to the mycobacterial surface where it can interact with host components. Interaction with epithelial cells and components of the extracellular matrix is mediated by the methylated lysine-rich C-terminal domain of the protein. The N-terminal end of HBHA contains a coiled coil motif which is involved in protein oligomerization and bacterial-bacterial aggregation. In this report, we will focus our attention on what is known about the structure of the HBHA protein and the protein function and role in TB pathogenesis.
Export Options
About this article
Cite this article as:
Delogu Giovanni, Fadda Giovanni and J. Brennan Michael, Impact of Structural Domains of the Heparin Binding Hemagglutinin of Mycobacterium tuberculosis on Function, Protein & Peptide Letters 2012; 19 (10) . https://dx.doi.org/10.2174/092986612802762697
DOI https://dx.doi.org/10.2174/092986612802762697 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Emerging Trends in Endometriosis Treatment - Review
Current Women`s Health Reviews Mechanism of Bioactive Transfer through Liposomal Bilayers
Current Drug Targets Target Validation: Linking Target and Chemical Properties to Desired Product Profile
Current Topics in Medicinal Chemistry Iron Acquisition Pathways as Targets for Antitubercular Drugs
Current Medicinal Chemistry Advances and Application of DNA-functionalized Nanoparticles
Current Medicinal Chemistry Is Targeting microRNAs the Philosopher’s Stone for Vascular Disease?
Current Vascular Pharmacology Pneumonia in the Elderly
Current Respiratory Medicine Reviews Small Ruminant Lentiviruses and Human Immunodeficiency Virus: Cousins that Take a Long View
Current HIV Research Peroxiredons: Tryparedoxin Peroxidase from Leishmania major
Current Regenerative Medicine (Discontinued) Drug Resistance of Antitubercular Agents at the Genetic Level in Mycobacterium Species: A Road Map to Drug Development for Counteracting the Resistance
Mini-Reviews in Organic Chemistry Withdrawal Notice: Drug Repurposing for Prospective Anti-Cancer Agents Along with the Clinical Status of the Repurposed Drug
Anti-Cancer Agents in Medicinal Chemistry Peptoids: Bio-Inspired Polymers as Potential Pharmaceuticals
Current Pharmaceutical Design The Role of Drug Transporters in the Pharmacokinetics of Antibiotics
Current Drug Metabolism Dibenzofurans from Lichens – A Pharmacological Overview
Current Topics in Medicinal Chemistry Therapeutic Drugs that Behave as Mechanism-Based Inhibitors of Cytochrome P450 3A4
Current Drug Metabolism Neuro-psychopharmacogenetics and Neurological Antecedents of Posttraumatic Stress Disorder: Unlocking the Mysteries of Resilience and Vulnerability
Current Neuropharmacology State of the Art of Nanobiotechnology Applications in Neglected Diseases
Current Nanoscience Recent Advances in the Development of Small-Molecular Inhibitors Target HIV Integrase-LEDGF/p75 Interaction
Mini-Reviews in Medicinal Chemistry Is Anticoagulation with Novel Oral Anticoagulants an Effective Treatment for Tuberculosis Patients not Achieving a Therapeutic Range with Vitamin K Antagonists? A Systematic Review
Cardiovascular & Hematological Disorders-Drug Targets Identification of Anti-cancer Peptides Based on Multi-classifier System
Combinatorial Chemistry & High Throughput Screening